[
  {
    "ts": "2025-08-29T08:51:18+00:00",
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN) Confident on Odronextamab Approval After Setbacks",
    "summary": "We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Regeneron Pharmaceuticals, Inc. is one of them. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) tops our list for being one of the cheap biotech stocks to buy. It is a biotechnology company developing treatments for serious diseases, including eye conditions, inflammatory disorders, […]",
    "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-regn-confident-085118704.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9bdecc1a-e982-391f-9ec9-19cc5db5c74e",
      "content": {
        "id": "9bdecc1a-e982-391f-9ec9-19cc5db5c74e",
        "contentType": "STORY",
        "title": "Regeneron Pharmaceuticals, Inc. (REGN) Confident on Odronextamab Approval After Setbacks",
        "description": "",
        "summary": "We recently compiled a list of the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Regeneron Pharmaceuticals, Inc. is one of them. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) tops our list for being one of the cheap biotech stocks to buy. It is a biotechnology company developing treatments for serious diseases, including eye conditions, inflammatory disorders, […]",
        "pubDate": "2025-08-29T08:51:18Z",
        "displayTime": "2025-08-29T08:51:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/a0c37756e263a60a8576e6fc84255063",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Regeneron Pharmaceuticals, Inc. (REGN) Confident on Odronextamab Approval After Setbacks",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nA0kaMX.J.bJl_kZtIXnZA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/a0c37756e263a60a8576e6fc84255063.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xx2MdOBzvD92lnclmhpRZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/a0c37756e263a60a8576e6fc84255063.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-regn-confident-085118704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pharmaceuticals-inc-regn-confident-085118704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]